Stephen M Moore

Stephen M Moore


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2024 in Journal of Imaging Informatics in Medicine
Verified
Journal Article
Open access
PDF file
DCDavid Clunie
David Clunie
FPFred Prior
Fred Prior
MRMichael W Rutherford
Michael W Rutherford
SMStephen M Moore
Stephen M Moore
WPWilliam Parker
William Parker
Keyvan FarahaniKeyvan Farahani
Keyvan Farahani
De-identification of medical images intended for research is a core requirement for data-sharing initiatives, particularly as the demand for data for artificial intelligence (AI) applications grows. The Center for Biomedical Informatics and Information Technology (CBIIT) of the US National Cancer Institute (NCI) convened a virtual workshop with the intent of summarizing the state of the art in de-identification technology and processes and exploring interesting aspects of the subject. This paper summarizes the highlights of the first day of the workshop, the recordings, and presentations of which are publicly available for review. The topics covered included the report of the Medical Image De-Identification Initiative (MIDI) Task Group on best practices and recommendations, tools for conventional approaches to de-identification, international approaches to de-identification, and an industry panel.

11 May 2023 in Tomography
Verified
Journal Article
Open access
PDF file
SMStephen M Moore
Stephen M Moore
JQJames D. Quirk
James D. Quirk
ALAndrew W. Lassiter
Andrew W. Lassiter
RLRichard Laforest
Richard Laforest
GAGregory D. Ayers
Gregory D. Ayers
KSKooresh Isaac Shoghi
Kooresh Isaac Shoghi
Preclinical imaging is a critical component in translational research with significant complexities in workflow and site differences in deployment. Importantly, the National Cancer Institute’s (NCI) precision medicine initiative emphasizes the use of translational co-clinical oncology models to address the biological and molecular bases of cancer prevention and treatment. The use of oncology models, such as patient-derived tumor xenografts (PDX) and genetically engineered mouse models (GEMMs), has ushered in an era of co-clinical trials by which preclinical studies can inform clinical trials and protocols, thus bridging the translational divide in cancer research. Similarly, preclinical imaging fills a translational gap as an enabling technology for translational imaging research. Unlike clinical imaging, where equipment manufacturers strive to meet standards in practice at clinical sites, standards are neither fully developed nor implemented in preclinical imaging. This fundamentally limits the collection and reporting of metadata to qualify preclinical imaging studies, thereby hindering open science and impacting the reproducibility of co-clinical imaging research. To begin to address these issues, the NCI co-clinical imaging research program (CIRP) conducted a survey to identify metadata requirements for reproducible quantitative co-clinical imaging. The enclosed consensus-based report summarizes co-clinical imaging metadata information (CIMI) to support quantitative co-clinical imaging research with broad implications for capturing co-clinical data, enabling interoperability and data sharing, as well as potentially leading to updates to the preclinical Digital Imaging and Communications in Medicine (DICOM) standard.

1 April 2023
Verified
Journal Article
Open access
DCDavid A. Clunie
David A. Clunie
AFAdam Flanders
Adam Flanders
ATAdam Taylor
Adam Taylor
BEBradley J. Erickson
Bradley J. Erickson
BBBrian Bialecki
Brian Bialecki
JHJohn Hsiao
John Hsiao